Home › Cervical Cancer
Cervical Cancer clinical trials recruiting in the U.S.
114 studies for Cervical Cancer are recruiting participants at sites across the United States.
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
Cities with the most studies
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Columbus, OH12 studies
- Baldwin Park, CA11 studies
- San Diego, CA11 studies
- Chicago, IL11 studies
- Atlanta, GA10 studies
- Philadelphia, PA10 studies
- Queens, NY10 studies
- Portland, OR10 studies
- Edison, NJ10 studies
- Cleveland, OH9 studies
- Pittsburgh, PA9 studies
- Washington, DC9 studies
- Durham, NC9 studies
- Birmingham, AL8 studies
- Baltimore, MD8 studies
- Minneapolis, MN8 studies
- Oklahoma City, OK8 studies
- Miami, FL8 studies
- Rochester, MN7 studies
- Denver, CO7 studies
- Grand Rapids, MI7 studies
- Seattle, WA7 studies
- New Orleans, LA7 studies
- Jacksonville, FL7 studies
- Salt Lake City, UT6 studies
- West Valley City, UT6 studies
- New Haven, CT6 studies
- Austin, TX6 studies
- Cincinnati, OH6 studies
- San Francisco, CA6 studies
By state
- Alabama9 studies
- Arizona9 studies
- Arkansas3 studies
- California38 studies
- Colorado12 studies
- Connecticut9 studies
- District of Columbia5 studies
- Florida28 studies
- Georgia14 studies
- Illinois14 studies
- Indiana4 studies
- Iowa5 studies
- Kansas4 studies
- Kentucky7 studies
- Louisiana8 studies
- Maryland13 studies
- Massachusetts20 studies
- Michigan13 studies
- Minnesota19 studies
- Mississippi3 studies
- Missouri12 studies
- Nebraska5 studies
- Nevada5 studies
- New Jersey14 studies
- New Mexico4 studies
- New York24 studies
- North Carolina14 studies
- Ohio24 studies
- Oklahoma12 studies
- Oregon11 studies
- Pennsylvania17 studies
- Rhode Island5 studies
- South Carolina6 studies
- Tennessee21 studies
- Texas45 studies
- Utah11 studies
- Virginia23 studies
- Washington11 studies
- West Virginia3 studies
- Wisconsin7 studies
Recently updated studies
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06319963A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT07216703Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT06952660Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT05051722A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06400472Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07524322Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05475171A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07109726E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05639972A Study of MGC026 in Participants With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06242470E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05686226KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05483491A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06330064A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community
RecruitingHealthy volunteers welcome
Ages 30 to 65 · Women · Updated Oct 22, 2026 · NCT07890402A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05914116GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT04977453A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Recruiting
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07741968Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06239194Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 14, 2026 · NCT05979610From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.